Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,119 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients

NCT01303887

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Aberdeen Royal Infirmary Aberdeen, United Kingdom
  • Ysbyty Gwynedd Bangor, United Kingdom
  • Birmingham Heartlands Birmingham, United Kingdom
  • Royal Bournemouth Hospital Bournemouth, United Kingdom
View all 73 locations
View Trial Details
Completed

Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma

NCT04836195

Conditions
Advanced Solid Tumor, B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer - Vancouver Vancouver, British Columbia, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
  • CR Centre Hospitalier de l'Université de Montréal - CHUM Montreal, Quebec, Canada
View Trial Details
Completed

Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea

NCT03288974

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations
  • Korea University Ansan Hospital Ansan, South Korea
  • Hallym University Sacred Heart Hospital Anyang, South Korea
  • Soonchunhyang University Hospital Bucheon-si, South Korea
  • Inje University Busan Paik Hospital Busan, South Korea
View all 33 locations
View Trial Details
Completed

Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis

NCT04064242

Conditions
Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +9 more
Locations
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Univ of Florida College of Medicine x Gainesville, Florida, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • John Hopkins Asthma And Alrgy Cntr Baltimore, Maryland, United States
View all 22 locations
View Trial Details
Completed

A Study to Evaluate Daratumumab in Transplant Eligible Participants With Previously Untreated Multiple Myeloma

NCT02541383

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • BE-Antwerp-ZNA Stuivenberg Antwerp, Belgium
  • AZ St Jan Brugge Oostende AV Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • UCL Saint-Luc Brussels, Belgium
View all 107 locations
View Trial Details

Related conditions